ALNYLAM PHARMACEUTICALS, INC. Stockholders' Equity 2007-2025 | ALNY
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is ALNYLAM PHARMACEUTICALS, INC.'s current stockholders' equity?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual stockholders' equity for 2025 was $789.2M, a 1076.33% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. stockholders' equity for the quarter ending December 31, 2025 was $789.2M.
What was ALNYLAM PHARMACEUTICALS, INC.'s stockholders' equity in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual stockholders' equity for 2024 was $67.1M, a 130.41% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s stockholders' equity in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual stockholders' equity for 2023 was $-220.6M, a 39.45% decline from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year stockholders' equity CAGR?
ALNYLAM PHARMACEUTICALS, INC. stockholders' equity grew at a compound annual growth rate (CAGR) of 4.93% from FY2020 to FY2025, going from $1.02B to $789.2M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $789.2M | +1076.3% | 10-K |
| FY2024 | $67.1M | +130.4% | 10-K |
| FY2023 | $-220.6M | -39.5% | 10-K |
| FY2022 | $-158.2M | -126.9% | 10-K |
| FY2021 | $588.2M | -42.1% | 10-K |
| FY2020 | $1.02B | -29.4% | 10-K |
| FY2019 | $1.44B | +10.5% | 10-K |
| FY2018 | $1.30B | -26.3% | 10-K |
| FY2017 | $1.77B | +92.0% | 10-K |
| FY2016 | $920.2M | -27.2% | 10-K |
| FY2015 | $1.26B | +35.1% | 10-K |
| FY2014 | $936.3M | +246.3% | 10-K |
| FY2013 | $270.3M | +101.7% | 10-K |
| FY2012 | $134.1M | +13.6% | 10-K |
| FY2011 | $118.0M | -25.4% | 10-K |
| FY2010 | $158.2M | -11.1% | 10-K |
| FY2009 | $178.0M | -12.0% | 10-K |
| FY2008 | $202.1M | +1.5% | 10-K |
| FY2007 | $199.2M | - | 10-K |